Areas where most women with PCOS often struggle most
On August 27, 2025, the FDA approved the first generic version of liraglutide (Saxenda) for weight loss in adults and adolescents with obesity and adults with overweight and at least one weight-related comorbid condition
I found it to be very helpful in my weight loss I only lost 2-3 lbs in the first month
As newer formulations reduce traditional barriers, clinicians are beginning to rethink when to initiate Read More Navigating Oral GLP-1s: When to Choose Pills Over Injections Feb 19, 2026 Articles, Diabetes, Therapies, Type 2 Diabetes, Type 2 Diabetes 3,501 views Oral GLP-1 therapy is quickly reshaping how we treat type 2 diabetes, especially for patients who hesitate at the thought of injections
Inflammation is a cellular response driven by your immune system